159 related articles for article (PubMed ID: 22331587)
1. Knock-down of plasminogen-activator inhibitor-1 enhances expression of E-cadherin and promotes epithelial differentiation of human pancreatic adenocarcinoma cells.
Lupu-Meiri M; Geras-Raaka E; Lupu R; Shapira H; Sandbank J; Segal L; Gershengorn MC; Oron Y
J Cell Physiol; 2012 Nov; 227(11):3621-8. PubMed ID: 22331587
[TBL] [Abstract][Full Text] [Related]
2. Suppression of the epidermal growth factor receptor inhibits epithelial-mesenchymal transition in human pancreatic cancer PANC-1 cells.
Chang ZG; Wei JM; Qin CF; Hao K; Tian XD; Xie K; Xie XH; Yang YM
Dig Dis Sci; 2012 May; 57(5):1181-9. PubMed ID: 22271412
[TBL] [Abstract][Full Text] [Related]
3. Suppression of the Epidermal Growth Factor-like Domain 7 and Inhibition of Migration and Epithelial-Mesenchymal Transition in Human Pancreatic Cancer PANC-1 Cells.
Wang YL; Dong FL; Yang J; Li Z; Zhi QM; Zhao X; Yang Y; Li DC; Shen XC; Zhou J
Asian Pac J Cancer Prev; 2015; 16(9):4065-9. PubMed ID: 25987088
[TBL] [Abstract][Full Text] [Related]
4. KCl cotransporter-3 down-regulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition.
Hsu YM; Chen YF; Chou CY; Tang MJ; Chen JH; Wilkins RJ; Ellory JC; Shen MR
Cancer Res; 2007 Nov; 67(22):11064-73. PubMed ID: 18006853
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma: Characterization in a 3D-cell culture model.
Gagliano N; Celesti G; Tacchini L; Pluchino S; Sforza C; Rasile M; Valerio V; Laghi L; Conte V; Procacci P
World J Gastroenterol; 2016 May; 22(18):4466-83. PubMed ID: 27182158
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen-induced aggregation of PANC-1 cells requires conversion to plasmin and is inhibited by endogenous plasminogen activator inhibitor-1.
Deshet N; Lupu-Meiri M; Espinoza I; Fili O; Shapira Y; Lupu R; Gershengorn MC; Oron Y
J Cell Physiol; 2008 Sep; 216(3):632-9. PubMed ID: 18366077
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 promotes pancreatic cancer cell differentiation and restores membranous E-cadherin via suppression of the epithelial-mesenchymal transition.
Salem AF; Bonuccelli G; Bevilacqua G; Arafat H; Pestell RG; Sotgia F; Lisanti MP
Cell Cycle; 2011 Nov; 10(21):3692-700. PubMed ID: 22041584
[TBL] [Abstract][Full Text] [Related]
8. Functional relevance of D,L-sulforaphane-mediated induction of vimentin and plasminogen activator inhibitor-1 in human prostate cancer cells.
Vyas AR; Singh SV
Eur J Nutr; 2014 Apr; 53(3):843-52. PubMed ID: 24092501
[TBL] [Abstract][Full Text] [Related]
9. S100 calcium-binding protein A6 promotes epithelial-mesenchymal transition through β-catenin in pancreatic cancer cell line.
Chen X; Liu X; Lang H; Zhang S; Luo Y; Zhang J
PLoS One; 2015; 10(3):e0121319. PubMed ID: 25799022
[TBL] [Abstract][Full Text] [Related]
10. The Crosstalk between Nrf2 and TGF-β1 in the Epithelial-Mesenchymal Transition of Pancreatic Duct Epithelial Cells.
Arfmann-Knübel S; Struck B; Genrich G; Helm O; Sipos B; Sebens S; Schäfer H
PLoS One; 2015; 10(7):e0132978. PubMed ID: 26226105
[TBL] [Abstract][Full Text] [Related]
11. Enhanced morphological and functional differences of pancreatic cancer with epithelial or mesenchymal characteristics in 3D culture.
Shichi Y; Sasaki N; Michishita M; Hasegawa F; Matsuda Y; Arai T; Gomi F; Aida J; Takubo K; Toyoda M; Yoshimura H; Takahashi K; Ishiwata T
Sci Rep; 2019 Jul; 9(1):10871. PubMed ID: 31350453
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin expression in obesity-associated, Kras-initiated pancreatic ductal adenocarcinoma in mice.
Stark AP; Chang HH; Jung X; Moro A; Hertzer K; Xu M; Schmidt A; Hines OJ; Eibl G
Surgery; 2015 Dec; 158(6):1564-72. PubMed ID: 26297056
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 expression is related to the epithelial-to-mesenchymal transition in human colon cancers.
Jang TJ; Jeon KH; Jung KH
Yonsei Med J; 2009 Dec; 50(6):818-24. PubMed ID: 20046424
[TBL] [Abstract][Full Text] [Related]
14. Expression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma.
Joo YE; Rew JS; Park CS; Kim SJ
Pancreatology; 2002; 2(2):129-37. PubMed ID: 12123093
[TBL] [Abstract][Full Text] [Related]
15. TLE1 promotes EMT in A549 lung cancer cells through suppression of E-cadherin.
Yao X; Ireland SK; Pham T; Temple B; Chen R; Raj MH; Biliran H
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):277-84. PubMed ID: 25446087
[TBL] [Abstract][Full Text] [Related]
16. PRL-3 promotes epithelial mesenchymal transition by regulating cadherin directly.
Liu Y; Zhou J; Chen J; Gao W; Le Y; Ding Y; Li J
Cancer Biol Ther; 2009 Jul; 8(14):1352-9. PubMed ID: 19440036
[TBL] [Abstract][Full Text] [Related]
17. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
[TBL] [Abstract][Full Text] [Related]
18. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer.
Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU
Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512
[TBL] [Abstract][Full Text] [Related]
19. HIF-2α promotes epithelial-mesenchymal transition through regulating Twist2 binding to the promoter of E-cadherin in pancreatic cancer.
Yang J; Zhang X; Zhang Y; Zhu D; Zhang L; Li Y; Zhu Y; Li D; Zhou J
J Exp Clin Cancer Res; 2016 Feb; 35():26. PubMed ID: 26842802
[TBL] [Abstract][Full Text] [Related]
20. Analysis of E-, N-cadherin, alpha-, beta-, and gamma-catenin expression in human pancreatic carcinoma cell lines.
Toyoda E; Doi R; Koizumi M; Kami K; Ito D; Mori T; Fujimoto K; Nakajima S; Wada M; Imamura M
Pancreas; 2005 Mar; 30(2):168-73. PubMed ID: 15714139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
